BioSpace17h
Supernus Taps Potential $300M US Opportunity With FDA Win for Parkinson’s Drug-Device Combo
The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...
Acrivon Therapeutics announces FDA granted BDD for ACR-368
Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...
Acrivon Therapeutics Gets FDA Breakthrough Device Designation for Cancer Identification
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
The Schall Law Firm Invites Shareholders With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
The Economist10h
Have doctors been wrong about how to treat Alzheimer’s disease?
Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...
Where to Find All Those Deleted Government Websites
In recent days—in response to directives from the Trump administration—thousands of federal agency web pages have been ...
Is Avoiding Microplastics Even Possible? Here's What Experts Say
Other potential microplastics sources our experts brought up are fabrics that touch your skin often (clothing, bedding, ...
New York Magazine18h
Trump Cabinet Confirmation Hearings: Schedule & How to Watch
Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...